HEADER IRON-BINDING PROTEIN 18-JAN-13 3ZJO TITLE M.ACETIVORANS PROTOGLOBIN IN COMPLEX WITH AZIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTOGLOBIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: METHANOSARCINA ACETIVORANS; SOURCE 3 ORGANISM_TAXID: 2214; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS IRON-BINDING PROTEIN, HAEM-DISTAL SITE MUTATION, AZIDE COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.PESCE,L.TILLEMAN,J.DONNE,E.ASTE,P.ASCENZI,C.CIACCIO,M.COLETTA, AUTHOR 2 L.MOENS,C.VIAPPIANI,S.DEWILDE,M.BOLOGNESI,M.NARDINI REVDAT 2 21-DEC-16 3ZJO 1 AUTHOR JRNL REVDAT 1 26-JUN-13 3ZJO 0 JRNL AUTH A.PESCE,L.TILLEMAN,J.DONNE,E.ASTE,P.ASCENZI,C.CIACCIO, JRNL AUTH 2 M.COLETTA,L.MOENS,C.VIAPPIANI,S.DEWILDE,M.BOLOGNESI, JRNL AUTH 3 M.NARDINI JRNL TITL STRUCTURE AND HAEM-DISTAL SITE PLASTICITY IN METHANOSARCINA JRNL TITL 2 ACETIVORANS PROTOGLOBIN. JRNL REF PLOS ONE V. 8 66144 2013 JRNL REFN ISSN 1932-6203 JRNL PMID 23776624 JRNL DOI 10.1371/JOURNAL.PONE.0066144 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0110 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.91 REMARK 3 DATA CUTOFF (SIGMA(F)) : NONE REMARK 3 COMPLETENESS FOR RANGE (%) : 96.59 REMARK 3 NUMBER OF REFLECTIONS : 33606 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.19256 REMARK 3 R VALUE (WORKING SET) : 0.18920 REMARK 3 FREE R VALUE : 0.25627 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.0 REMARK 3 FREE R VALUE TEST SET COUNT : 1782 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.800 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.847 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2476 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.16 REMARK 3 BIN R VALUE (WORKING SET) : 0.265 REMARK 3 BIN FREE R VALUE SET COUNT : 122 REMARK 3 BIN FREE R VALUE : 0.380 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3216 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 94 REMARK 3 SOLVENT ATOMS : 311 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.745 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.01 REMARK 3 B22 (A**2) : 0.04 REMARK 3 B33 (A**2) : -0.06 REMARK 3 B12 (A**2) : 0.00 REMARK 3 B13 (A**2) : -0.01 REMARK 3 B23 (A**2) : 0.00 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.661 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.156 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.107 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 7.762 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.960 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.926 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3430 ; 0.015 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4704 ; 1.447 ; 2.025 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 394 ; 5.256 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 172 ;38.713 ;23.721 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 544 ;13.340 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 18 ;17.164 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 470 ; 0.099 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2696 ; 0.008 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1924 ; 1.035 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3129 ; 1.644 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1506 ; 2.424 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1567 ; 3.512 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 3430 ; 1.579 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): 311 ; 5.284 ; 3.000 REMARK 3 SPHERICITY; BONDED ATOMS (A**2): 3310 ; 2.855 ; 3.000 REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. REMARK 4 REMARK 4 3ZJO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 18-JAN-13. REMARK 100 THE PDBE ID CODE IS EBI-55483. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35389 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.80 REMARK 200 RESOLUTION RANGE LOW (A) : 41.62 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.1 REMARK 200 DATA REDUNDANCY : 3.5 REMARK 200 R MERGE (I) : 0.08 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.40 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.90 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.5 REMARK 200 DATA REDUNDANCY IN SHELL : 3.5 REMARK 200 R MERGE FOR SHELL (I) : 0.40 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.40 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2VEB REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.01 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG 4000, 0.2 M LITHIUM REMARK 280 SULPHATE, 0.1 M HEPES PH 7.5, 0.01 M POTASSIUM REMARK 280 FERRICYANIDE, 0.1 M SODIUM AZIDE REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 59.94000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 24.41000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 59.94000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 24.41000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6640 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15430 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -67.6 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 VAL A 3 REMARK 465 GLU A 4 REMARK 465 LYS A 5 REMARK 465 MET B 1 REMARK 465 SER B 2 REMARK 465 VAL B 3 REMARK 465 GLU B 4 REMARK 465 LYS B 5 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 106 -165.56 -120.09 REMARK 500 ASN A 126 -2.53 73.16 REMARK 500 LYS A 160 35.37 -149.25 REMARK 500 ASN B 126 -9.19 78.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 TYR B 147 24.7 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 200 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HEM A 200 NC REMARK 620 2 HEM A 200 NB 86.4 REMARK 620 3 HIS A 120 NE2 94.3 93.6 REMARK 620 4 AZI A 798 N1 82.7 85.0 176.7 REMARK 620 5 HEM A 200 NA 177.2 94.4 88.3 94.8 REMARK 620 6 HEM A 200 ND 93.2 177.7 88.7 92.6 85.9 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM B 200 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HEM B 200 NA REMARK 620 2 HEM B 200 ND 89.1 REMARK 620 3 AZI B 798 N1 92.8 91.9 REMARK 620 4 HIS B 120 NE2 85.9 91.4 176.4 REMARK 620 5 HEM B 200 NB 89.9 178.7 87.3 89.4 REMARK 620 6 HEM B 200 NC 179.4 91.4 86.8 94.5 89.6 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AZI A 798 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM B 200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AZI B 798 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3ZJH RELATED DB: PDB REMARK 900 TRP(60)B9ALA MUTATION OF M.ACETIVORANS PROTOGLOBIN IN REMARK 900 COMPLEX WITH CYANIDE REMARK 900 RELATED ID: 3ZJI RELATED DB: PDB REMARK 900 TYR(61)B10ALA MUTATION OF M.ACETIVORANS PROTOGLOBIN IN REMARK 900 COMPLEX WITH CYANIDE REMARK 900 RELATED ID: 3ZJJ RELATED DB: PDB REMARK 900 PHE(93)E11LEU MUTATION OF M.ACETIVORANS PROTOGLOBIN IN REMARK 900 COMPLEX WITH CYANIDE REMARK 900 RELATED ID: 3ZJL RELATED DB: PDB REMARK 900 LEU(142)G4ALA MUTATION OF M.ACETIVORANS PROTOGLOBIN IN REMARK 900 COMPLEX WITH CYANIDE REMARK 900 RELATED ID: 3ZJM RELATED DB: PDB REMARK 900 ILE(149)G11PHE MUTATION OF M.ACETIVORANS PROTOGLOBIN REMARK 900 IN COMPLEX WITH CYANIDE REMARK 900 RELATED ID: 3ZJN RELATED DB: PDB REMARK 900 M.ACETIVORANS PROTOGLOBIN IN COMPLEX WITH CYANIDE REMARK 900 RELATED ID: 3ZJP RELATED DB: PDB REMARK 900 M.ACETIVORANS PROTOGLOBIN IN COMPLEX WITH IMIDAZOLE REMARK 900 RELATED ID: 3ZJQ RELATED DB: PDB REMARK 900 M.ACETIVORANS PROTOGLOBIN IN COMPLEX WITH NICOTINAMIDE REMARK 999 REMARK 999 SEQUENCE REMARK 999 C101S MUTATED FOR CRYSTALLIZATION PURPOSES DBREF 3ZJO A 1 195 UNP Q8TLY9 Q8TLY9_METAC 1 195 DBREF 3ZJO B 1 195 UNP Q8TLY9 Q8TLY9_METAC 1 195 SEQADV 3ZJO SER A 101 UNP Q8TLY9 CYS 101 ENGINEERED MUTATION SEQADV 3ZJO SER B 101 UNP Q8TLY9 CYS 101 ENGINEERED MUTATION SEQRES 1 A 195 MET SER VAL GLU LYS ILE PRO GLY TYR THR TYR GLY GLU SEQRES 2 A 195 THR GLU ASN ARG ALA PRO PHE ASN LEU GLU ASP LEU LYS SEQRES 3 A 195 LEU LEU LYS GLU ALA VAL MET PHE THR ALA GLU ASP GLU SEQRES 4 A 195 GLU TYR ILE GLN LYS ALA GLY GLU VAL LEU GLU ASP GLN SEQRES 5 A 195 VAL GLU GLU ILE LEU ASP THR TRP TYR GLY PHE VAL GLY SEQRES 6 A 195 SER HIS PRO HIS LEU LEU TYR TYR PHE THR SER PRO ASP SEQRES 7 A 195 GLY THR PRO ASN GLU LYS TYR LEU ALA ALA VAL ARG LYS SEQRES 8 A 195 ARG PHE SER ARG TRP ILE LEU ASP THR SER ASN ARG SER SEQRES 9 A 195 TYR ASP GLN ALA TRP LEU ASP TYR GLN TYR GLU ILE GLY SEQRES 10 A 195 LEU ARG HIS HIS ARG THR LYS LYS ASN GLN THR ASP ASN SEQRES 11 A 195 VAL GLU SER VAL PRO ASN ILE GLY TYR ARG TYR LEU VAL SEQRES 12 A 195 ALA PHE ILE TYR PRO ILE THR ALA THR MET LYS PRO PHE SEQRES 13 A 195 LEU ALA ARG LYS GLY HIS THR PRO GLU GLU VAL GLU LYS SEQRES 14 A 195 MET TYR GLN ALA TRP PHE LYS ALA THR THR LEU GLN VAL SEQRES 15 A 195 ALA LEU TRP SER TYR PRO TYR VAL LYS TYR GLY ASP PHE SEQRES 1 B 195 MET SER VAL GLU LYS ILE PRO GLY TYR THR TYR GLY GLU SEQRES 2 B 195 THR GLU ASN ARG ALA PRO PHE ASN LEU GLU ASP LEU LYS SEQRES 3 B 195 LEU LEU LYS GLU ALA VAL MET PHE THR ALA GLU ASP GLU SEQRES 4 B 195 GLU TYR ILE GLN LYS ALA GLY GLU VAL LEU GLU ASP GLN SEQRES 5 B 195 VAL GLU GLU ILE LEU ASP THR TRP TYR GLY PHE VAL GLY SEQRES 6 B 195 SER HIS PRO HIS LEU LEU TYR TYR PHE THR SER PRO ASP SEQRES 7 B 195 GLY THR PRO ASN GLU LYS TYR LEU ALA ALA VAL ARG LYS SEQRES 8 B 195 ARG PHE SER ARG TRP ILE LEU ASP THR SER ASN ARG SER SEQRES 9 B 195 TYR ASP GLN ALA TRP LEU ASP TYR GLN TYR GLU ILE GLY SEQRES 10 B 195 LEU ARG HIS HIS ARG THR LYS LYS ASN GLN THR ASP ASN SEQRES 11 B 195 VAL GLU SER VAL PRO ASN ILE GLY TYR ARG TYR LEU VAL SEQRES 12 B 195 ALA PHE ILE TYR PRO ILE THR ALA THR MET LYS PRO PHE SEQRES 13 B 195 LEU ALA ARG LYS GLY HIS THR PRO GLU GLU VAL GLU LYS SEQRES 14 B 195 MET TYR GLN ALA TRP PHE LYS ALA THR THR LEU GLN VAL SEQRES 15 B 195 ALA LEU TRP SER TYR PRO TYR VAL LYS TYR GLY ASP PHE HET HEM A 200 44 HET AZI A 798 3 HET HEM B 200 44 HET AZI B 798 3 HETNAM AZI AZIDE ION HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETSYN HEM HEME FORMUL 3 AZI 2(N3 1-) FORMUL 4 HEM 2(C34 H32 FE N4 O4) FORMUL 5 HOH *311(H2 O) HELIX 1 1 ASN A 21 VAL A 32 1 12 HELIX 2 2 THR A 35 GLU A 50 1 16 HELIX 3 3 GLN A 52 HIS A 67 1 16 HELIX 4 4 HIS A 67 TYR A 72 1 6 HELIX 5 5 ASN A 82 ARG A 103 1 22 HELIX 6 6 ASP A 106 HIS A 121 1 16 HELIX 7 7 GLY A 138 ALA A 158 1 21 HELIX 8 8 THR A 163 SER A 186 1 24 HELIX 9 9 TYR A 187 TYR A 189 5 3 HELIX 10 10 ASN B 21 VAL B 32 1 12 HELIX 11 11 THR B 35 GLU B 50 1 16 HELIX 12 12 GLN B 52 SER B 66 1 15 HELIX 13 13 HIS B 67 TYR B 72 1 6 HELIX 14 14 ASN B 82 ARG B 103 1 22 HELIX 15 15 ASP B 106 HIS B 121 1 16 HELIX 16 16 GLY B 138 ARG B 159 1 22 HELIX 17 17 THR B 163 SER B 186 1 24 HELIX 18 18 TYR B 187 TYR B 189 5 3 LINK FE HEM A 200 NE2 HIS A 120 1555 1555 2.16 LINK N1 AZI A 798 FE HEM A 200 1555 1555 1.97 LINK FE HEM B 200 NE2 HIS B 120 1555 1555 1.95 LINK N2 AZI B 798 FE HEM B 200 1555 1555 2.69 LINK N1 AZI B 798 FE HEM B 200 1555 1555 1.99 CISPEP 1 LYS A 160 GLY A 161 0 -23.17 SITE 1 AC1 25 LEU A 70 TYR A 73 PHE A 74 TYR A 85 SITE 2 AC1 25 VAL A 89 ARG A 92 PHE A 93 TRP A 96 SITE 3 AC1 25 TYR A 112 ARG A 119 HIS A 120 LYS A 125 SITE 4 AC1 25 ASN A 126 ILE A 137 TYR A 141 LEU A 142 SITE 5 AC1 25 PHE A 145 ILE A 146 VAL A 182 TRP A 185 SITE 6 AC1 25 AZI A 798 HOH A2104 HOH A2105 HOH A2136 SITE 7 AC1 25 HOH A2140 SITE 1 AC2 3 TYR A 61 PHE A 93 HEM A 200 SITE 1 AC3 26 LEU B 70 TYR B 73 PHE B 74 TYR B 85 SITE 2 AC3 26 VAL B 89 ARG B 92 PHE B 93 TRP B 96 SITE 3 AC3 26 TYR B 112 ARG B 119 HIS B 120 LYS B 125 SITE 4 AC3 26 ASN B 126 ILE B 137 TYR B 141 LEU B 142 SITE 5 AC3 26 PHE B 145 ILE B 146 ILE B 149 VAL B 182 SITE 6 AC3 26 TRP B 185 AZI B 798 HOH B2078 HOH B2079 SITE 7 AC3 26 HOH B2093 HOH B2098 SITE 1 AC4 4 TYR B 61 VAL B 89 PHE B 93 HEM B 200 CRYST1 119.880 48.820 80.590 90.00 122.60 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008342 0.000000 0.005335 0.00000 SCALE2 0.000000 0.020483 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014729 0.00000 MASTER 359 0 4 18 0 0 16 6 0 0 0 30 END